Newsfeeds - Spark Newswire

1 minute read

AbCellera Announces Presentation Of Data From CD3 T-Cell Engager Platform At Society for Immunotherapy of Cancer November 11 2022

Today, 3:53 AM

AbCellera (NASDAQ:ABCL) today announced a presentation at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, to be held virtually and at the Boston Convention & Exhibition Center from November 8

ABCL

8 minute read

Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday

By Lisa Levin

Today, 3:53 AM

Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.

ABCL

4 minute read

Coinbase, Trade Desk, H&R Block And Some Other Big Gainers From Wednesday

By Lisa Levin

Today, 3:53 AM

U.S. stocks closed higher on Wednesday following the release of inflation data. Here is the list of some big stocks moving higher in the previous session.

ABCL

5 minute read

Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 3:53 AM

Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 39.5% to $2.0380.

ABCL

3 minute read

Why Is CarLotz Higher By More Than 30%: Here Are 28 Stocks Moving Premarket

By Lisa Levin

Today, 3:53 AM

Gainers ObsEva SA (NASDAQ: OBSV) shares rose 33.8% to $0.4080 in pre-market trading. ObsEva recently announced a $31 million debt retirement and $11 million debt refinancing.

ABCL

22 minute read

Earnings Scheduled For August 9, 2022

By Benzinga Insights

Today, 3:53 AM

Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.

AAIC

2 minute read

News

Versant Ventures Collaborates With AbCellera To Accelerate Drug Development For Its Portfolio Of Biotech Companies

By Benzinga Newsdesk

Today, 3:53 AM

AbCellera (NASDAQ:ABCL) and Versant Ventures today announced a multi-year collaboration to discover therapeutic antibodies for multiple targets selected by Versant’s portfolio of biologics-focused biotechs. Versant

ABCL

2 minute read

Earnings

AbCellera Biologics’s Return On Capital Employed Insights

By Benzinga Insights

Today, 3:53 AM

According to Benzinga Pro, during Q1, AbCellera Biologics (NASDAQ:ABCL) earned $168.57 million, a 181.2% increase from the preceding quarter. AbCellera Biologics also posted a total of $316.58 million in sales, a 127.22% increase since Q4.

ABCL

1 minute read

Cramer Shares His Thoughts On Stem, Marvell Technology And More

By Craig Jones

Today, 3:53 AM

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Marvell Technology Inc (NASDAQ: MRVL) is the "best when it comes to 5G, the best in high-performance computing.

ABCL

44 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 3:53 AM

On Wednesday, 807 companies reached new 52-week lows.

AADI